Astera Labs (NASDAQ:ALAB – Get Free Report) was upgraded by investment analysts at Royal Bank Of Canada to a “moderate buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.
ALAB has been the topic of a number of other reports. Northland Securities increased their target price on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 price objective for the company. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Monday, November 17th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Finally, TD Cowen lowered their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $190.63.
Read Our Latest Analysis on ALAB
Astera Labs Stock Up 1.3%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business’s revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, analysts anticipate that Astera Labs will post 0.34 EPS for the current year.
Insider Activity
In other news, General Counsel Philip Mazzara sold 4,620 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the sale, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. The trade was a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 576,936 shares of company stock worth $87,409,540 over the last three months. Insiders own 12.50% of the company’s stock.
Institutional Trading of Astera Labs
Hedge funds have recently added to or reduced their stakes in the business. Assetmark Inc. boosted its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares during the period. Oliver Lagore Vanvalin Investment Group bought a new stake in shares of Astera Labs during the second quarter valued at about $29,000. Hilltop National Bank lifted its holdings in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the period. Aventura Private Wealth LLC bought a new position in Astera Labs in the 4th quarter valued at about $33,000. Finally, Bernard Wealth Management Corp. acquired a new position in Astera Labs during the 2nd quarter valued at about $36,000. Institutional investors own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Buy Alert: $8 AI Stock
- 53% Gains In 4 Years. Then 51% In Under 11 Months.
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
